Matches in SemOpenAlex for { <https://semopenalex.org/work/W2535920727> ?p ?o ?g. }
- W2535920727 endingPage "1740" @default.
- W2535920727 startingPage "1735" @default.
- W2535920727 abstract "Background: Modularity in total hip arthroplasty facilitates intraoperative restoration of patient anatomy. Although dual-taper modular total hip arthroplasty offers potential advantages for optimizing the hip center of rotation, it has been associated with modular taper corrosion. This corrosion has led to adverse local tissue reactions (pseudotumors) at the neck-stem junction and elevated metal-ion levels. However, the occurrence of taper-corrosion-related pseudotumors in patients who remain asymptomatic following total hip arthroplasty with a dual-taper modular femoral stem remains largely unknown. The aims of this study were (1) to determine the prevalence of asymptomatic pseudotumors by utilizing metal artifact reduction sequence magnetic resonance imaging (MARS-MRI) and (2) compare serum metal-ion levels between symptomatic and asymptomatic patients with a dual-taper modular stem total hip replacement. Methods: We performed a retrospective cross-sectional study of 97 consecutive patients who had been treated with a dual-taper modular femoral stem total hip arthroplasty. Eighty-three patients were stratified into symptomatic and asymptomatic groups and evaluated with MARS-MRI, measurement of serum metal-ion levels, and the University of California at Los Angeles (UCLA) functional hip score. Results: The prevalence of pseudotumors as determined with MARS-MRI was 15% in our asymptomatic patients and 36% in the overall cohort. The median serum cobalt level and cobalt/chromium ratio were significantly higher in patients with a pseudotumor than in those without a pseudotumor (8.0 versus 2.0 μg/L [p = 0.004] and 10.3 versus 2.4 μg/L [p = 0.012], respectively). However, there was no significant difference in the serum cobalt level or cobalt/chromium ratio between symptomatic patients with a pseudotumor and asymptomatic patients with a pseudotumor (7.6 versus 6.2 μg/L [p = 0.37] and 8.3 versus 10.6 μg/L [p = 0.46], respectively). The UCLA scores of asymptomatic patients with a pseudotumor were similar to those of patients without a pseudotumor (6.7 versus 6.6). Conclusions: The prevalence of asymptomatic taper-corrosion-related pseudotumors on MARS-MRI in this study demonstrated that the absence of symptoms does not exclude the presence of adverse local tissue reactions. Elevated cobalt levels and cobalt/chromium ratios were associated with the presence of pseudotumors in asymptomatic and symptomatic patients. Cross-sectional imaging such as MARS-MRI is indicated for patients with elevated metal-ion levels. A longitudinal study is required to determine whether asymptomatic patients with taper-corrosion-related pseudotumors will develop symptoms with time. Level of Evidence: Therapeutic Level IV . See Instructions for Authors for a complete description of levels of evidence." @default.
- W2535920727 created "2016-10-28" @default.
- W2535920727 creator A5011770179 @default.
- W2535920727 creator A5027451949 @default.
- W2535920727 creator A5041865996 @default.
- W2535920727 creator A5059911459 @default.
- W2535920727 creator A5066125096 @default.
- W2535920727 creator A5085555501 @default.
- W2535920727 date "2016-10-19" @default.
- W2535920727 modified "2023-10-16" @default.
- W2535920727 title "Asymptomatic Pseudotumors in Patients with Taper Corrosion of a Dual-Taper Modular Femoral Stem" @default.
- W2535920727 cites W1545593992 @default.
- W2535920727 cites W1832790934 @default.
- W2535920727 cites W1922942728 @default.
- W2535920727 cites W1939602621 @default.
- W2535920727 cites W1965091521 @default.
- W2535920727 cites W1965897070 @default.
- W2535920727 cites W1966978310 @default.
- W2535920727 cites W1968533895 @default.
- W2535920727 cites W1973016905 @default.
- W2535920727 cites W1973629097 @default.
- W2535920727 cites W1977998262 @default.
- W2535920727 cites W1987866183 @default.
- W2535920727 cites W2013810816 @default.
- W2535920727 cites W2013855614 @default.
- W2535920727 cites W2021629826 @default.
- W2535920727 cites W2026017994 @default.
- W2535920727 cites W2027926595 @default.
- W2535920727 cites W2039220878 @default.
- W2535920727 cites W2039376739 @default.
- W2535920727 cites W20403205 @default.
- W2535920727 cites W2041927983 @default.
- W2535920727 cites W2044122439 @default.
- W2535920727 cites W2051885106 @default.
- W2535920727 cites W2066112407 @default.
- W2535920727 cites W2073471723 @default.
- W2535920727 cites W2077255370 @default.
- W2535920727 cites W2094608901 @default.
- W2535920727 cites W2096630520 @default.
- W2535920727 cites W2097203719 @default.
- W2535920727 cites W2103350783 @default.
- W2535920727 cites W2105188510 @default.
- W2535920727 cites W2118862534 @default.
- W2535920727 cites W2126625456 @default.
- W2535920727 cites W2134652871 @default.
- W2535920727 cites W2151316022 @default.
- W2535920727 cites W2192437577 @default.
- W2535920727 cites W2194628711 @default.
- W2535920727 cites W2206419091 @default.
- W2535920727 cites W2321282344 @default.
- W2535920727 cites W349398711 @default.
- W2535920727 doi "https://doi.org/10.2106/jbjs.15.01325" @default.
- W2535920727 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27869625" @default.
- W2535920727 hasPublicationYear "2016" @default.
- W2535920727 type Work @default.
- W2535920727 sameAs 2535920727 @default.
- W2535920727 citedByCount "25" @default.
- W2535920727 countsByYear W25359207272017 @default.
- W2535920727 countsByYear W25359207272018 @default.
- W2535920727 countsByYear W25359207272019 @default.
- W2535920727 countsByYear W25359207272020 @default.
- W2535920727 countsByYear W25359207272021 @default.
- W2535920727 countsByYear W25359207272022 @default.
- W2535920727 countsByYear W25359207272023 @default.
- W2535920727 crossrefType "journal-article" @default.
- W2535920727 hasAuthorship W2535920727A5011770179 @default.
- W2535920727 hasAuthorship W2535920727A5027451949 @default.
- W2535920727 hasAuthorship W2535920727A5041865996 @default.
- W2535920727 hasAuthorship W2535920727A5059911459 @default.
- W2535920727 hasAuthorship W2535920727A5066125096 @default.
- W2535920727 hasAuthorship W2535920727A5085555501 @default.
- W2535920727 hasConcept C126838900 @default.
- W2535920727 hasConcept C141071460 @default.
- W2535920727 hasConcept C143409427 @default.
- W2535920727 hasConcept C2776211809 @default.
- W2535920727 hasConcept C2777910003 @default.
- W2535920727 hasConcept C2778120723 @default.
- W2535920727 hasConcept C2778336525 @default.
- W2535920727 hasConcept C2779967601 @default.
- W2535920727 hasConcept C71924100 @default.
- W2535920727 hasConceptScore W2535920727C126838900 @default.
- W2535920727 hasConceptScore W2535920727C141071460 @default.
- W2535920727 hasConceptScore W2535920727C143409427 @default.
- W2535920727 hasConceptScore W2535920727C2776211809 @default.
- W2535920727 hasConceptScore W2535920727C2777910003 @default.
- W2535920727 hasConceptScore W2535920727C2778120723 @default.
- W2535920727 hasConceptScore W2535920727C2778336525 @default.
- W2535920727 hasConceptScore W2535920727C2779967601 @default.
- W2535920727 hasConceptScore W2535920727C71924100 @default.
- W2535920727 hasIssue "20" @default.
- W2535920727 hasLocation W25359207271 @default.
- W2535920727 hasLocation W25359207272 @default.
- W2535920727 hasOpenAccess W2535920727 @default.
- W2535920727 hasPrimaryLocation W25359207271 @default.
- W2535920727 hasRelatedWork W2018144414 @default.
- W2535920727 hasRelatedWork W2042472674 @default.
- W2535920727 hasRelatedWork W2045240138 @default.
- W2535920727 hasRelatedWork W2132079435 @default.